Press Release · Press Releases
Zhimeng Biopharma has completed the patients enrollment of its investigational drug, CB03-154, in the pivotal Phase 2/3 ALS clinical trial.
SHANGHAI, Oct. 31, 2026 /PRNewswire/ -- Shanghai Zhimeng Biopharma, Inc. ( "Zhimeng Biopharma") announced today that its independently developed next-generation potassium channel opener, CB03-154, intended for the treatment of amyotrophic lateral sclerosis (ALS), has successfully...
This press release summary is reproduced from the issuer's public feed.
Read the full release at PR NewswireOriginal publisher: PR Newswire
Spotted an error? Request a correction · Corrections Policy
Related stories
Drive to Great | BAIC FOTON Africa Partners Conference Successfully Held, Accelerating Localization Strategy
PORT ELIZABETH, South Africa, Oct. 31, 2026 /PRNewswire/ -- On October 29, the BAIC FOTON Africa Partners Conference, themed "Drive to Great," was held at Nelson Mandela Bay Stadium in Port Elizabeth, South Africa. Nearly 700 participants attended, including Chinese and African political...
PR Newswire ·
TCL Donates Ultra-Low-Power Display System to the Youth Olympic Village, Bringing Advanced Display Technology to Everyday Use
The donation of the display, featuring TCL CSOT's high-brightness Field Sequential Color technology, continues TCL's long-term commitment to the African market DAKAR, Senegal, Oct. 31, 2026 /PRNewswire/ -- TCL, a Worldwide Olympic and Paralympic Partner, donated an ultra-low-power display...
PR Newswire ·
GAC Wins 8 Awards, Including 4 First Prizes, Showcasing Technological Innovation Strength
SUZHOU, China, Oct. 31, 2026 /PRNewswire/ -- On October 28, GAC won 8 awards at the 2026 China-SAE Science and Technology Award ceremony in Suzhou, Jiangsu. In the fields of automotive chips, electric drive, vehicle safety, intelligent driving governance and body design, four first prizes...
PR Newswire ·
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Main Street Financial Services Corp. (NYSE: MSWV)
NEW YORK, Oct. 31, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The...
PR Newswire ·
APOD: 2026 October 31 – Night on a Spooky Planet
APOD Science APOD APOD: 2026 October 31 –… Today’s APOD Archive Submissions Index Search Calendar RSS Education About Discuss APOD Astronomy Picture of the Day Discover the cosmos! Each day a different image or photograph of our fascinating universe is featured, along with a brief explanation written by a professional astronomer. Night on a […]
NASA ·
Purina Films Docuseries, 'A Different Breed,' Sweeps Three Daytime Emmy® Awards
Emmy-winning series celebrates the extraordinary bond between people and pets and marks a major milestone for Purina Films ST. LOUIS, Oct. 30, 2026 /PRNewswire/ -- Purina is celebrating a major milestone for Purina Films as A Different Breed, its original nine-episode documentary series...
PR Newswire ·